According to Evolent Health's latest financial reports the company's current earnings are HK$2.46 Billion. In 2023 the company made an earning of -HK$1.16 Billion a decrease over its 2022 earnings that were of -HK$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -HK$0.45 Billion | -61.42% |
2023 | -HK$1.16 Billion | 218.68% |
2022 | -HK$0.37 Billion | 962.73% |
2021 | -HK$34.01 Million | -98.57% |
2020 | -HK$2.39 Billion | -1.93% |
2019 | -HK$2.43 Billion | 542.29% |
2018 | -HK$0.38 Billion | -33.12% |
2017 | -HK$0.57 Billion | -69.57% |
2016 | -HK$1.86 Billion | 456.55% |
2015 | -HK$0.34 Billion | 269.05% |
2014 | -HK$90.48 Million |